Results 51 to 60 of about 5,313 (208)

Liraglutide Treatment Reverses Unconventional Cellular Defects in Induced Pluripotent Stem Cell–Derived β-Cells Harboring a Partially Functional WFS1 Variant

open access: yesDiabetes
Wolfram syndrome 1 (WS1) is a rare genetic disorder caused by WFS1 variants that disrupt wolframin, an endoplasmic reticulum-associated protein essential for cellular stress responses, Ca2+ homeostasis, and autophagy.
Silvia Torchio   +10 more
semanticscholar   +2 more sources

Impairment of visual function and retinal ER stress activation in Wfs1-deficient mice.

open access: yesPLoS ONE, 2014
Wolfram syndrome is an early onset genetic disease (1/180,000) featuring diabetes mellitus and optic neuropathy, associated to mutations in the WFS1 gene.
Delphine Bonnet Wersinger   +6 more
doaj   +1 more source

Multidimensional analysis and therapeutic development using patient iPSC–derived disease models of Wolfram syndrome

open access: yesJCI Insight, 2022
Wolfram syndrome is a rare genetic disorder largely caused by pathogenic variants in the WFS1 gene and manifested by diabetes mellitus, optic nerve atrophy, and progressive neurodegeneration.
Rie Asada Kitamura   +16 more
doaj   +1 more source

The Impact of Mutations in Wolframin on Psychiatric Disorders

open access: yesFrontiers in Pediatrics, 2021
Wolfram Syndrome is a rare autosomal recessive disease characterized by early-onset diabetes mellitus, neurodegeneration, and psychological disorders. Mutations in the gene WFS1, coding for the protein wolframin, cause Wolfram Syndrome and are associated
Saira Munshani   +4 more
doaj   +1 more source

The miR-668 binding site variant rs1046322 on WFS1 is associated with obesity in Southeast Asians

open access: yesFrontiers in Endocrinology, 2023
The Wolfram syndrome 1 gene (WFS1) is the main causative locus for Wolfram syndrome, an inherited condition characterized by childhood-onset diabetes mellitus, optic atrophy, and deafness.
Maha M. Hammad   +10 more
doaj   +1 more source

Valproate, a mood stabilizer, induces WFS1 expression and modulates its interaction with ER stress protein GRP94. [PDF]

open access: yesPLoS ONE, 2009
Valproate is a standard treatment for bipolar disorder and a first-line mood stabilizer. The molecular mechanisms underlying its actions in bipolar disorder are unclear.
Chihiro Kakiuchi   +5 more
doaj   +1 more source

WFS1 protein expression correlates with clinical progression of optic atrophy in patients with Wolfram syndrome. [PDF]

open access: yes, 2021
BACKGROUND: Wolfram syndrome (WFS) is a rare disorder characterised by childhood-onset diabetes mellitus and progressive optic atrophy. Most patients have variants in the WFS1 gene.
Hu, Kun   +14 more
core   +3 more sources

Delineating Wolfram-like syndrome: A systematic review and discussion of the WFS1-associated disease spectrum.

open access: yesSurvey of ophthalmology, 2023
Wolfram-like syndrome (WFLS) is a recently described autosomal dominant disorder with phenotypic similarities to autosomal recessive Wolfram syndrome (WS), including optic atrophy, hearing impairment, and diabetes mellitus.
C. de Muijnck   +4 more
semanticscholar   +1 more source

Wolfram syndrome in the Japanese population; molecular analysis of WFS1 gene and characterization of clinical features. [PDF]

open access: yesPLoS ONE, 2014
BACKGROUND: Wolfram syndrome (WFS) is a recessive neurologic and endocrinologic degenerative disorder, and is also known as DIDMOAD (Diabetes Insipidus, early-onset Diabetes Mellitus, progressive Optic Atrophy and Deafness) syndrome.
Kimie Matsunaga   +15 more
doaj   +1 more source

Loss of Function of WFS1 Causes ER Stress-Mediated Inflammation in Pancreatic Beta-Cells

open access: yesFrontiers in Endocrinology, 2022
Wolfram syndrome is a rare genetic disorder characterized by juvenile-onset diabetes mellitus, optic nerve atrophy, hearing loss, diabetes insipidus, and progressive neurodegeneration.
Shuntaro Morikawa   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy